Then there are regulators at FDA, NICE, the EMA, and the German IQWiG who have shaken cautious bureaucracies, streamlined decision-making, pushed for transparency, and, in some cases, triggered an uproar by demanding that the industry delivers the breakthroughs it keeps boasting about, as a condition for charging premium prices.
FORBES: Connect